Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.58 |
| ▸ | THRB | P10828 | 1/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | PYGB | P11216 | 3/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | CD69 | Q07108 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
| ▸ | OGA | O60502 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18573708 | 1.00 | ALDH1A1 (0.58) | ALDH1A1THRBMAPK1SMN1; SMN2PYGB | |
| SCHEMBL18735615 | 1.00 | ALDH1A1 (0.58) | ALDH1A1THRBMAPK1SMN1; SMN2PYGB | |
| SCHEMBL20842452 | 1.00 | ALDH1A1 (0.58) | ALDH1A1THRBMAPK1SMN1; SMN2PYGB | |
| SCHEMBL17771655 | 0.91 | ALDH1A1 (0.58) | ALDH1A1THRBMAPK1SMN1; SMN2PYGB | |
| SCHEMBL12936319 | 0.91 | ALDH1A1 (0.58) | ALDH1A1THRBMAPK1SMN1; SMN2PYGB | |
| SCHEMBL23735602 | 0.87 | MAPK1 (0.56) | ALDH1A1THRBMAPK1SMN1; SMN2PYGB | |
| SCHEMBL14473245 | 0.87 | ALDH1A1 (0.46) | ALDH1A1THRBMAPK1SMN1; SMN2PYGB | |
| SCHEMBL16393013 | 0.87 | ALDH1A1 (0.55) | ALDH1A1THRBMAPK1SMN1; SMN2PYGB | |
| SCHEMBL23640116 | 0.85 | CD69 (0.58) | ALDH1A1THRBMAPK1SMN1; SMN2CD69 | |
| SCHEMBL23640154 | 0.85 | CD69 (0.58) | ALDH1A1THRBMAPK1SMN1; SMN2CD69 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11739122-B2 | Glycopeptide antibiotic compounds, methods for producing the same, and uses thereof | ACADEMIA SINICA (TW) | 2023-08-29 | — | — | US | disclosed |
| US-20220169790-A1 | CARBOHYDRATE LIGANDS THAT BIND TO ANTIBODIES AGAINST GLYCOEPITOPES OF GLYCOSPHINGOLIPIDS | UNIV BASEL (CH) | 2022-06-02 | — | — | US | disclosed |
| US-20210198284-A1 | GOLD COMPOSITIONS AND METHODS OF USE THEREOF | UNIVERSITY OF MASSACHUSETTS | 2021-07-01 | — | — | US | disclosed |
| US-20200291071-A1 | GLYCOPEPTIDE COMPOUNDS, METHODS FOR PRODUCING THE SAME, AND USES THEREOF | ACADEMIA SINICA (TW) | 2020-09-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210198284-A1 | GOLD COMPOSITIONS AND METHODS OF USE THEREOF | LSS, LGALS7; LGALS7B, LGALS3 | ALDH1A1 493/4885THRB 4449/4885MAPK1 4566/4885 |
| US-20200291071-A1 | GLYCOPEPTIDE COMPOUNDS, METHODS FOR PRODUCING THE SAME, AND USES THEREOF | B3GAT3, MGAM, GALNT14 | ALDH1A1 3371/4885THRB 2039/4885MAPK1 3577/4885 |
| US-11739122-B2 | Glycopeptide antibiotic compounds, methods for producing the same, and uses thereof | NGLY1, NRDC, MGAT3 | ALDH1A1 3782/4885THRB 128/4885MAPK1 2346/4885 |
| US-20220169790-A1 | CARBOHYDRATE LIGANDS THAT BIND TO ANTIBODIES AGAINST GLYCOEPITOPES OF GLYCOSPHINGOLIPIDS | SIGLEC7, GALC, GBA1 | ALDH1A1 2449/4885THRB 2336/4885MAPK1 3057/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.